Rona Therapeutics
Privately held: no public share price
Assets
(3 total)
3Total Assets
0Approved
0Phase 3 / Filed
3Phase 1–2 / Early
2Diseases
Quick filter:
| Target & Modality | |||
|---|---|---|---|
| Phase 1/2 | APOC3RNA / oligonucleotide | Cardiovascular Disease / Dyslipidemia Hypertriglyceridemia | |
| Phase 1 | PCSK9RNA / oligonucleotide | Atherosclerotic Cardiovascular Disease | |
| Phase 1 | PCSK9 and LPA (bivalent, dual-target)RNA / oligonucleotide | Atherosclerotic Cardiovascular Disease |
Upcoming events
No upcoming trial completions or earnings dates on record for this company's assets.
Financial reports
No financial reports recorded.